An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for INCYTE Corp
| Ticker | INCY |
| FIGI | BBG000BNPSQ9 |
| CUSIP | 45337C102 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 537 / 7.8% |
| Percentage held by institutional investors | 86.6% |
About
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland. The company was created in 2002 through the merger of Incyte Pharmaceuticals, founded in Palo Alto, California in 1991 and Incyte Genomics, Inc. of Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.Incyte Corporation currently develops and manufacturers prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia